These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17289760)

  • 1. Evaluation of the Etest method for fosfomycin susceptibility of ESBL-producing Klebsiella pneumoniae.
    López-Cerero L; de Cueto M; Díaz-Guerrero MA; Morillo C; Pascual A
    J Antimicrob Chemother; 2007 Apr; 59(4):810-2. PubMed ID: 17289760
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin].
    Hernández MS; García JA; Muñoz JL
    Rev Esp Quimioter; 2009 Mar; 22(1):25-9. PubMed ID: 19308743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.
    Giakkoupi P; Tzouvelekis LS; Daikos GL; Miriagou V; Petrikkos G; Legakis NJ; Vatopoulos AC
    J Clin Microbiol; 2005 Jan; 43(1):494-6. PubMed ID: 15635025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods.
    Camarlinghi G; Parisio EM; Antonelli A; Nardone M; Coppi M; Giani T; Mattei R; Rossolini GM
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):74-76. PubMed ID: 30126624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae.
    Netikul T; Leelaporn A; Leelarasmee A; Kiratisin P
    Int J Antimicrob Agents; 2010 Jun; 35(6):609-10. PubMed ID: 20189774
    [No Abstract]   [Full Text] [Related]  

  • 6. Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases.
    Karageorgopoulos DE; Miriagou V; Tzouvelekis LS; Spyridopoulou K; Daikos GL
    J Antimicrob Chemother; 2012 Nov; 67(11):2777-9. PubMed ID: 22782489
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
    Garau J
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of
    Elliott ZS; Barry KE; Cox HL; Stoesser N; Carroll J; Vegesana K; Kotay S; Sheppard AE; Wailan A; Crook DW; Parikh H; Mathers AJ
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31340992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
    Mendonça N; Ferreira E; Louro D; ; Caniça M
    Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of tigecycline against enterobacteria producing two or more extended-spectrum beta-lactamases.
    Vázquez MF; Romero ED; García MI; Rodríguez JA; Bellido JL
    Int J Antimicrob Agents; 2008 Dec; 32(6):541-3. PubMed ID: 18789848
    [No Abstract]   [Full Text] [Related]  

  • 12. False susceptibility to cefotetan reported by MicroScan for DHA-type AmpC beta-lactamase-producing Klebsiella pneumoniae.
    Lee SY; Park YJ; Oh EJ; Yoo JK; Park JJ; Park KG; Han K
    Clin Microbiol Infect; 2007 May; 13(5):539-41. PubMed ID: 17331122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosfomycin susceptibility of isolates with blaKPC-2 from Brazil.
    Tuon FF; Rocha JL; Formighieri MS; Sfair S; Bertoldi MB; Palmeiro JK; Dalla Costa LM
    J Infect; 2013 Sep; 67(3):247-9. PubMed ID: 23639842
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Conejo MC; Hernández JR; Pascual A
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
    J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran.
    Shahcheraghi F; Moezi H; Feizabadi MM
    Med Sci Monit; 2007 Nov; 13(11):BR247-250. PubMed ID: 17968291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IS
    Kieffer N; Poirel L; Mueller L; Mancini S; Nordmann P
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.